Author Archives: David Melamed

Study Showcases Wide Range of Clinical, Laboratory Findings in CAD

Researchers found a wide range of demographic, clinical, and laboratory characteristics when studying eight patients with cold agglutinin disease (CAD). The findings revealed that treatment with corticosteroids, surgical removal of the spleen, and the use of CellCept (mycophenolate mofetil) — an antirejection medicine given to transplant patients…

Experts Share Guidelines for Diagnosis, Treatment of CAD, Other Autoimmune Hemolytic Anemias

Autoimmune hemolytic anemia (AIHA) experts gathered in Vienna, Austria, in November 2017 for the First International Consensus Meeting with the goal of summarizing current research into diagnosis and treatment of the rare genetic disorders. Now, after three subsequent meetings at medical conferences, the researchers and physicians have published their conclusions and…